Inventor
GFESSER GREGORY A
US35 patents
⚠️ This page may combine multiple inventors who share the name “GFESSER GREGORY A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
ABBVIE SARL
7 patentsUS9981910B2May 29, 2018
Substituted pyrrolidines and methods of use
ABBVIE SARL31 citations92
US10259810B2Apr 16, 2019
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations82
US9890158B2Feb 13, 2018
N-sulfonylated pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL5 citations81
US10647717B2May 12, 2020
N-sulfonylated-pyrazolo[3,4-b]pyridin-6-carboxamides and method of use
ABBVIE SARL1 citations71
US10399940B2Sep 3, 2019
Substituted pyrrolidines and methods of use
ABBVIE SARL4 citations71
US10428017B2Oct 1, 2019
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE SARL1 citations61
US10130622B2Nov 20, 2018
Compounds for treatment of cystic fibrosis
ABBVIE SARL0 citations37
ABBOTT LAB
6 patentsUS7683084B2Mar 23, 2010
Thiazoline and oxazoline derivatives and their methods of use
ABBOTT LAB43 citations96
US7153889B2Dec 26, 2006
Bicyclic-substituted amines as histamine-3 receptor ligands
ABBOTT LAB18 citations92
US7741364B2Jun 22, 2010
Pyrrole derivatives and their methods of use
ABBOTT LAB23 citations89
US6969730B2Nov 29, 2005
Amines as histamine-3 receptor ligands and their therapeutic applications
ABBOTT LAB11 citations74
US7538138B2May 26, 2009
Amines as histamine-3 receptor ligands and their therapeutic applications
ABBOTT LAB2 citations63
US8383657B2Feb 26, 2013
Thiazolylidine urea and amide derivatives and methods of use thereof
ABBOTT LAB3 citations62
ABBVIE OVERSEAS SARL
5 patentsUS10988454B2Apr 27, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL1 citations70
US10981890B2Apr 20, 2021
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations59
US10844041B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10844042B2Nov 24, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
US10829473B2Nov 10, 2020
Modulators of the cystic fibrosis transmembrane conductance regulator protein and methods of use
ABBVIE OVERSEAS SARL0 citations49
ABBVIE INC
4 patentsSCHRIMPF MICHAEL R
3 patentsUS9063126B2Jun 23, 2015
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R2 citations61
US9625475B2Apr 18, 2017
Indole and indoline derivatives and methods of use thereof
SCHRIMPF MICHAEL R1 citations51
US8268853B2Sep 18, 2012
3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof
SCHRIMPF MICHAEL R0 citations51
BLACK LAWRENCE A
3 patentsUS8796297B2Aug 5, 2014
4-substituted-2-amino-pyrimidine derivatives
BLACK LAWRENCE A1 citations50
US8580968B2Nov 12, 2013
Benzothiazole and benzooxazole derivatives and methods of use
BLACK LAWRENCE A0 citations48
US8153813B2Apr 10, 2012
Benzothiazole and benzooxazole derivatives and methods of use
BLACK LAWRENCE A1 citations48